Vaping

High school seniors in states where cannabis is permitted for medical use only were more likely to report past-year cannabis vaping than those in states where it is prohibited or legalized for adult use, a recent study found.

Since the CDC declared e-cigarette or vaping product use-associated lung injury, or EVALI, an epidemic in 2019, researchers have been working to understand its causes and harms and how to stimy the rise of this disease.

The FDA has issued marketing denial orders to R.J. Reynolds Vapor Company for two popular menthol e-cigarette products today, stating that the company cannot distribute or market them in the United States.

Healio Pulmonology has compiled the top news from the FDA posted in 2022.

Patients with e-cigarette- or vaping-associated lung injury, or EVALI, frequently showed long-term cognitive impairment, respiratory limitations and mood disorders, according to a study published in Annals of the American Thoracic Society.

Although the prevalence of e-cigarette use peaked in 2019, the age of initiation of nicotine continues to decrease, and the intensity of use rises annually, researchers reported in JAMA Network Open.

Daily e-cigarette use among teens “seemed to accelerate” after 2017, according to a new study in JAMA Network Open.

Reduced flow-mediated dilation was observed among both e-cigarette and traditional cigarette users, but circulating levels of certain inflammatory and thrombotic mediators differed between the two groups, researchers reported.

The U.S. Department of Justice has filed for permanent injunctions against six e-cigarette manufacturers on behalf of the FDA, according to a press release.

New data show that more than 2.5 million middle and high school students in the U.S. report using e-cigarettes, and the FDA has announced additional steps it is taking to help curb the pervasive use.